SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-053033
Filing Date
2020-11-10
Accepted
2020-11-10 17:02:58
Documents
43
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q tcon-10q_20200930.htm 10-Q 1742376
2 EX-31.1 tcon-ex311_6.htm EX-31.1 9266
3 EX-32.1 tcon-ex321_7.htm EX-32.1 5648
  Complete submission text file 0001564590-20-053033.txt   5000760

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT tcon-20200930.xml EX-101.INS 822419
5 XBRL TAXONOMY EXTENSION SCHEMA tcon-20200930.xsd EX-101.SCH 48694
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tcon-20200930_cal.xml EX-101.CAL 31506
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tcon-20200930_def.xml EX-101.DEF 135499
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE tcon-20200930_lab.xml EX-101.LAB 320850
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tcon-20200930_pre.xml EX-101.PRE 227968
Mailing Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122
Business Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122 858-550-0780
Tracon Pharmaceuticals, Inc. (Filer) CIK: 0001394319 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36818 | Film No.: 201302008
SIC: 2836 Biological Products, (No Diagnostic Substances)